JR, H., R, G., X, Y., CA, K., YV, V., JA, B., . . . MD, K. (2025). Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy. The Journal of allergy and clinical immunology, 156(2), 468. https://doi.org/10.1016/j.jaci.2025.04.010
Chicago Style (17th ed.) CitationJR, Humphrey, et al. "Baseline Basophil Activation and Early Suppression Is Associated with Clinical Outcome After Peanut Sublingual Immunotherapy." The Journal of Allergy and Clinical Immunology 156, no. 2 (2025): 468. https://doi.org/10.1016/j.jaci.2025.04.010.
MLA (9th ed.) CitationJR, Humphrey, et al. "Baseline Basophil Activation and Early Suppression Is Associated with Clinical Outcome After Peanut Sublingual Immunotherapy." The Journal of Allergy and Clinical Immunology, vol. 156, no. 2, 2025, p. 468, https://doi.org/10.1016/j.jaci.2025.04.010.